Literature DB >> 15878760

Predictive factors for distant metastasis from oral and oropharyngeal squamous cell carcinoma.

Luiz Paulo Kowalski1, André Lopes Carvalho, Antonio Vitor Martins Priante, José Magrin.   

Abstract

The presence of distant metastasis after the initial treatment of head and neck squamous cell carcinoma is not considered a common event and is associated with a poor outcome. The objective of this study was to investigate the prevalence and risk factors associated with the diagnosis of distant metastasis in oral and oropharyngeal carcinoma patients. The medical charts of 2327 patients treated from 1954 to 1997 were reviewed. They were 1703 patients (73.2%) with oral cavity and 624 (26.8%), oropharyngeal tumours. Regarding the primary treatment: 637 patients (27.4%) underwent surgery alone; 1147 (49.3%), radiotherapy alone and 543 (23.3%), combined treatment (surgery and radiotherapy). During the follow-up period after the initial treatment, 89 patients (3.8%) were diagnosed with distant metastasis. The variables associated with the distant metastasis-free survival were: tumour site (p=0.008); T stage (p<0.001); N stage (p<0.001); treatment performed (p<0.001) and decade of admission at the institution (p<0.001). The multivariate analysis (Cox regression) showed that the clinical stage (p=0.007); treatment performed (p=0.012) and decade of admission at the institution (p=0.004) were independent predictive factors for distant metastasis. Distant metastasis has been diagnosed more frequently in the latter decade and the significant predictors associated with its presence were the advanced clinical stage and patients who had undergone combined treatment.

Entities:  

Mesh:

Year:  2005        PMID: 15878760     DOI: 10.1016/j.oraloncology.2005.01.012

Source DB:  PubMed          Journal:  Oral Oncol        ISSN: 1368-8375            Impact factor:   5.337


  26 in total

1.  Analysis of ECOG performance status in head and neck squamous cell carcinoma patients: association with sociodemographical and clinical factors, and overall survival.

Authors:  Gefter Thiago Batista Corrêa; Gabriela Alencar Bandeira; Bruna Gonçalves Cavalcanti; Francis Balduíno Guimarães Santos; João Felício Rodrigues Rodrigues Neto; André Luiz Sena Guimarães; Desirée Sant'Ana Haikal; Alfredo Maurício Batista De Paula
Journal:  Support Care Cancer       Date:  2012-11       Impact factor: 3.603

2.  Oral cancer in men and women: are there differences?

Authors:  Astrid L Kruse; Marius Bredell; Klaus W Grätz
Journal:  Oral Maxillofac Surg       Date:  2010-10-31

3.  Orthotopic non-metastatic and metastatic oral cancer mouse models.

Authors:  Manish V Bais; Maria Kukuruzinska; Philip C Trackman
Journal:  Oral Oncol       Date:  2015-02-11       Impact factor: 5.337

4.  NIPA-like domain containing 1 is a novel tumor-promoting factor in oral squamous cell carcinoma.

Authors:  Tomonori Sasahira; Yukiko Nishiguchi; Miyako Kurihara-Shimomura; Chie Nakashima; Hiroki Kuniyasu; Tadaaki Kirita
Journal:  J Cancer Res Clin Oncol       Date:  2018-02-20       Impact factor: 4.553

5.  Predictive factors for simultaneous distant metastasis in head and neck cancer patients during the diagnostic work-up.

Authors:  Carlos Miguel Chiesa-Estomba; Maria Soriano-Reixach; Ekhiñe Larruscain-Sarasola; Jon Alexander Sistiaga-Suarez; Jose Angel González-García; Amaia Sanchez-Martin; Laura Basterretxea-Badiola; Naiara Sagastibelta; Xabier Altuna-Mariezcurrena
Journal:  Eur Arch Otorhinolaryngol       Date:  2021-02-07       Impact factor: 2.503

6.  Effectiveness of "OralDETECT": a Repetitive Test-enhanced, Corrective Feedback Method Competency Assessment Tool for Early Detection of Oral Cancer.

Authors:  Rosnah Binti Zain; Deepak Gowda Sadashivappa Pateel; Anand Ramanathan; Thomas George Kallarakkal; Gou Rean Wong; Yi Hsin Yang; Zuraiza Mohamad Zaini; Norliwati Ibrahim; Shivani Kohli; Callum Durward
Journal:  J Cancer Educ       Date:  2022-04       Impact factor: 2.037

Review 7.  Metastatic disease in head & neck oncology.

Authors:  Paolo Pisani; Mario Airoldi; Anastasia Allais; Paolo Aluffi Valletti; Mariapina Battista; Marco Benazzo; Roberto Briatore; Salvatore Cacciola; Salvatore Cocuzza; Andrea Colombo; Bice Conti; Alberto Costanzo; Laura Della Vecchia; Nerina Denaro; Cesare Fantozzi; Danilo Galizia; Massimiliano Garzaro; Ida Genta; Gabriela Alejandra Iasi; Marco Krengli; Vincenzo Landolfo; Giovanni Vittorio Lanza; Mauro Magnano; Maurizio Mancuso; Roberto Maroldi; Laura Masini; Marco Carlo Merlano; Marco Piemonte; Silvia Pisani; Adriele Prina-Mello; Luca Prioglio; Maria Gabriella Rugiu; Felice Scasso; Agostino Serra; Guido Valente; Micol Zannetti; Angelo Zigliani
Journal:  Acta Otorhinolaryngol Ital       Date:  2020-04       Impact factor: 2.124

8.  Salivary alpha-1-antitrypsin and macrophage migration inhibitory factor may be potential prognostic biomarkers for oncologic treatment-induced severe oral mucositis.

Authors:  Natália Rangel Palmier; Adriana Franco Paes Leme; Tatiane De Rossi; Guilherme Pimentel Telles; Karina Morais-Faria; Luiz Paulo Kowalski; Gustavo Nader Marta; Thaís Bianca Brandão; Praveen R Arany; César Augusto Migliorati; Alan Roger Santos-Silva; Ana Carolina Prado-Ribeiro
Journal:  Support Care Cancer       Date:  2020-10-02       Impact factor: 3.603

9.  Immunohistochemical markers of distant metastasis in laryngeal and hypopharyngeal squamous cell carcinomas.

Authors:  Juan P Rodrigo; Patricia Martínez; Eva Allonca; Laura Alonso-Durán; Carlos Suárez; Aurora Astudillo; Juana María García-Pedrero
Journal:  Clin Exp Metastasis       Date:  2013-12-27       Impact factor: 5.150

10.  Prognostic Impact of Metastatic Site and Pattern in Patients with Metastatic Head and Neck Cancer.

Authors:  Craig A Bollig; Christopher I Newberry; Tabitha L I Galloway; Robert P Zitsch; Elyse K Hanly; Vivian L Zhu; Nitin Pagedar; Rohit Nallani; Andres M Bur; William C Spanos; Jeffrey B Jorgensen
Journal:  Laryngoscope       Date:  2020-10-24       Impact factor: 3.325

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.